1. Home
  2. VANI vs NXPLW Comparison

VANI vs NXPLW Comparison

Compare VANI & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • NXPLW
  • Stock Information
  • Founded
  • VANI 1998
  • NXPLW N/A
  • Country
  • VANI United States
  • NXPLW United States
  • Employees
  • VANI N/A
  • NXPLW 166
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NXPLW Telecommunications Equipment
  • Sector
  • VANI Health Care
  • NXPLW Telecommunications
  • Exchange
  • VANI Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • VANI N/A
  • NXPLW N/A
  • IPO Year
  • VANI 2014
  • NXPLW N/A
  • Fundamental
  • Price
  • VANI $1.03
  • NXPLW $0.15
  • Analyst Decision
  • VANI Strong Buy
  • NXPLW
  • Analyst Count
  • VANI 1
  • NXPLW 0
  • Target Price
  • VANI $4.00
  • NXPLW N/A
  • AVG Volume (30 Days)
  • VANI 116.8K
  • NXPLW 6.4K
  • Earning Date
  • VANI 05-12-2025
  • NXPLW 03-31-2025
  • Dividend Yield
  • VANI N/A
  • NXPLW N/A
  • EPS Growth
  • VANI N/A
  • NXPLW N/A
  • EPS
  • VANI N/A
  • NXPLW N/A
  • Revenue
  • VANI N/A
  • NXPLW $66,482,000.00
  • Revenue This Year
  • VANI N/A
  • NXPLW N/A
  • Revenue Next Year
  • VANI N/A
  • NXPLW N/A
  • P/E Ratio
  • VANI N/A
  • NXPLW N/A
  • Revenue Growth
  • VANI N/A
  • NXPLW 179.89
  • 52 Week Low
  • VANI $0.91
  • NXPLW $0.25
  • 52 Week High
  • VANI $2.09
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • VANI 45.99
  • NXPLW N/A
  • Support Level
  • VANI $1.02
  • NXPLW N/A
  • Resistance Level
  • VANI $1.05
  • NXPLW N/A
  • Average True Range (ATR)
  • VANI 0.04
  • NXPLW 0.00
  • MACD
  • VANI 0.00
  • NXPLW 0.00
  • Stochastic Oscillator
  • VANI 71.43
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: